The calculated cumulative cancer incidence by age 70 years was high in MLH1 and MSH2 (72%) carriers and lower (at borderline significance) in MSH6 (54%) and PMS2 (18%) carriers.
← all excerpts
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
1
—
—